Ingevity (NGVT)
(Delayed Data from NYSE)
$45.15 USD
+0.71 (1.60%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $45.14 -0.01 (-0.02%) 6:08 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$45.15 USD
+0.71 (1.60%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $45.14 -0.01 (-0.02%) 6:08 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Zacks News
Wall Street's Insights Into Key Metrics Ahead of Ingevity (NGVT) Q4 Earnings
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Ingevity (NGVT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Green Plains Renewable Energy (GPRE) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Green Plains (GPRE) delivered earnings and revenue surprises of -25% and 13.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ingevity (NGVT) Extends Distributorship With TRiiSO for Capa
by Zacks Equity Research
TRiiSO's technical support strengths complement Ingevity's (NGVT) commitment to providing solutions to challenging formulation issues.
Ingevity's (NGVT) Earnings and Sales Miss Estimates in Q3
by Zacks Equity Research
Lower volumes due to weak industrial demand hurt Ingevity's (NGVT) Advanced Polymer Technologies and the Industrial Specialties business lines in Q3.
Compared to Estimates, Ingevity (NGVT) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Green Plains Renewable Energy (GPRE) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Green Plains (GPRE) delivered earnings and revenue surprises of 800% and 9.61%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Ingevity (NGVT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PPG Industries (PPG) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PPG Industries (PPG) delivered earnings and revenue surprises of 6.15% and 0.50%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Is Ingevity (NGVT) Down 2.7% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ingevity (NGVT) Inks Renewable Energy Project for US Locations
by Zacks Equity Research
Ingevity (NGVT) will receive 85 megawatts of capacity at a new NextEra Energy Resources solar site constructed in North Texas as part of the agreement.
Ingevity (NGVT) Q2 Earnings Meet, Revenues Miss Estimates
by Zacks Equity Research
Ingevity's (NGVT) Q2 revenues gain from higher prices across its segments, and increased volumes in the Performance Materials segment and the pavement technologies business line.
Ingevity (NGVT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Ingevity (NGVT) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ingevity (NGVT) Meets Q2 Earnings Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 0% and 0.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Ecolab (ECL) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of 2.48% and 0.37%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 29th
by Zacks Equity Research
NGVT, IART and BRDG have been added to the Zacks Rank #5 (Strong Sell) List on June 29, 2023.
Ingevity (NGVT) Awarded OK Biodegradable SOIL Certification
by Zacks Equity Research
The SOIL certification is Ingevity's (NGVT) fifth TUV Austria OK certification for Capa thermoplastics products.
New Strong Sell Stocks for June 22nd
by Zacks Equity Research
NGVT, FCCO and HP have been added to the Zacks Rank #5 (Strong Sell) List on June 22, 2023.
Do Options Traders Know Something About Ingevity (NGVT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Ingevity (NGVT) stock based on the movements in the options market lately.
Why Is Ingevity (NGVT) Down 26.3% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ingevity's (NGVT) Earnings and Revenues Lag Estimates in Q1
by Zacks Equity Research
A slower recovery in automotive in China and continued destocking weigh on Ingevity's (NGVT) Q1 results.
Ingevity (NGVT) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -13.49% and 4.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Green Plains Renewable Energy (GPRE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ingevity (NGVT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why You Should Keep Ingevity (NGVT) Stock in Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) gains on solid demand and higher selling prices in its Performance Chemicals segment, actions to drive long-term growth and price hike measures to mitigate cost inflation.